P-glycoprotein inhibition as a strategy to augment antidepressant delivery across the blood-brain barrier: preclinical pharmacokinetic and pharmacodynamic studies

F. E. O'Brien; Gerard Clarke; Ted Dinan; Brendan T  Griffin; J.F.  Cryan

P-glycoprotein inhibition as a strategy to augment antidepressant delivery across the blood-brain barrier: preclinical pharmacokinetic and pharmacodynamic studies

F. E. O'Brien
, Gerard Clarke
, Ted Dinan
, Brendan T Griffin
, J.F. Cryan

University College London

Research output: Contribution to conference › Paper › peer-review

Original language	English (Ireland)
Publication status	Published - 2013
Event	3rd Annual UK & Ireland Early Career BBB Symposium - Cambridge, United Kingdom Duration: 22 Nov 2013 → …

Conference

Conference	3rd Annual UK & Ireland Early Career BBB Symposium
Country/Territory	United Kingdom
Period	22/11/13 → …

Cite this

@conference{fd984d08ee424731838a74df4a2b354a,

title = "P-glycoprotein inhibition as a strategy to augment antidepressant delivery across the blood-brain barrier: preclinical pharmacokinetic and pharmacodynamic studies",

author = "O'Brien, \{F. E.\} and Gerard Clarke and Ted Dinan and Griffin, \{Brendan T\} and J.F. Cryan",

year = "2013",

language = "English (Ireland)",

note = "3rd Annual UK \& Ireland Early Career BBB Symposium ; Conference date: 22-11-2013",

}

P-glycoprotein inhibition as a strategy to augment antidepressant delivery across the blood-brain barrier: preclinical pharmacokinetic and pharmacodynamic studies. / O'Brien, F. E.; Clarke, Gerard; Dinan, Ted et al.
2013. Paper presented at 3rd Annual UK & Ireland Early Career BBB Symposium, United Kingdom.

Research output: Contribution to conference › Paper › peer-review